Show simple item record

dc.creatorMisirkić Marjanović, Maja
dc.creatorVučićević, Ljubica
dc.creatorKosić, Milica
dc.creatorPaunović, Verica
dc.creatorArsikin-Csordas, Katarina
dc.creatorRistić, Biljana
dc.creatorMarić, Nađa
dc.creatorBošnjak, Mihajlo
dc.creatorZogović, Nevena
dc.creatorMandić, Miloš
dc.creatorKravić-Stevović, Tamara
dc.creatorMartinović, Tamara
dc.creatorĆirić, Darko
dc.creatorMirčić, Aleksandar
dc.creatorPetričević, Saša
dc.creatorBumbaširević, Vladimir
dc.creatorHarhaji-Trajković, Ljubica
dc.creatorTrajković, Vladimir
dc.date.accessioned2023-11-25T19:06:43Z
dc.date.available2023-11-25T19:06:43Z
dc.date.issued2019
dc.identifier.urihttps://www.mitoeagle.org/index.php/MiP2019/MitoEAGLE_Belgrade_RS
dc.identifier.urihttp://radar.ibiss.bg.ac.rs/handle/123456789/6353
dc.description.abstractWe analyzed the impact of mitochondrial damage in anticancer action of combining lysosomal membrane permeabilization (LMP)-inducing agent N- dodecylimidazole (NDI)[1] with glycolytic inhibitor 2-deoxy-D-glucose (2DG) and in antipsychotic action of atypical antipsychotic olanzapine. NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing ATP depletion, mitochondrial damage and reactive oxygen species production, eventually leading to necrotic death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant tocopherol, suggesting the involvement of LMP and oxidative stress in the observed cytotoxicity. Moreover, the combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6 mice by inducing necrotic death of tumor cells. Based on these results, we propose that NDI-triggered LMPcauses initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss, and reactive oxygen species production, culminating in necrotic cell death. We also investigated the role of autophagy, a controlled cellular self-digestion process, in regulating survival of neurons exposed to olanzapine. Olanzapine induced autophagy in human SH-SY5Y neuronal cell line, as confirmed by the increase in autophagic flux and presence of autophagic vesicles, fusion of autophagosomes with lysosomes, and increase in the expression of autophagy-related (ATG) genes ATG4B, ATG5, andATG7. The production of reactive oxygen species, but not modulation of the main autophagy repressor mTOR or its upstream regulators AMP-activated protein kinase and AKT1, was responsible for olanzapine-triggered autophagy. Olanzapine-mediated oxidative stress also induced mitochondrial depolarization and damage, and the autophagic clearance of dysfunctional mitochondria [2] was confirmed by electron microscopy, colocalization of autophagosome associated MAP1LC3B (LC3B) and mitochondria, and mitochondrial association with the autophagic cargo receptor p62. While olanzapine-triggered mitochondrial damage was not visibly toxic to SH-SY5Ycells, their death was readily initiated upon the inhibition of autophagy with pharmacological inhibitors, RNA interference knockdown of BECN1 and LC3B. The treatment of mice with olanzapine increased the brain levels of LC3B-II and mRNA encoding Atg4b,Atg5, Atg7, Atg12, Gabarap, and Becn1. These data indicate that olanzapine-triggered autophagy protects neurons from otherwise fatal mitochondrial damage, and that inhibition of autophagy might unmask the neurotoxic action of the drug. References; 1. Repnik U, Turk B (2010) Lysosomal-mitochondrial cross-talk during cell death. Mitochondrion10: 662-669. 2. Wang K, Klionsky DJ(2011) Mitochondrial removal by autophagy. Autophagy 7:297-300.sr
dc.language.isoensr
dc.publisherThe Mitochondrial Physiology Societysr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Integrated and Interdisciplinary Research (IIR or III)/41025/RS//sr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173053/RS//sr
dc.rightsopenAccesssr
dc.sourceProgramme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbiasr
dc.subjectmitochondriasr
dc.subjectantipshychoticsr
dc.subjectanticancersr
dc.subjectoxidative stresssr
dc.subjectautophagysr
dc.subjectnecrosissr
dc.titleDual role of mitochondrial damage in anticancer and antipsychotic treatmentsr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.rights.holder© 2019 by The Mitochondrial Physiology Societysr
dc.description.otherProgramme abstract book: 14th Conference on Mitochondrial Physiology: Mitochondrial function: changes during life cycle and in noncommunicable diseases: COST MitoEAGLE perspectives and MitoEAGLE WG and MC Meeting: MiP2019/MitoEAGLE; 2019 Oct 13-16; Belgrade, Serbia. The Mitochondrial Physiology Society; 2019. p. 29.sr
dc.citation.spage29
dc.citation.epage29
dc.type.versionpublishedVersionsr
dc.identifier.fulltexthttps://radar.ibiss.bg.ac.rs/bitstream/id/16078/bitstream_16078.pdf
dc.citation.rankM34
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_ibiss_6353


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record